Editorial ArticleDrug Discovery & Development
Charting the future of oligonucleotide bioanalysis
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies
Biopharmaceuticals are proteins and other compounds (such as nucleic acids) produced by living organisms that have uses as therapeutics or for in vivo diagnostics. The most well known example of a biopharmaceutical product, and the first to be approved for therapeutic use, was recombinant human insulin.
As oligonucleotide therapeutics reshape drug discovery, AAPS is leading a collaborative effort to establish robust bioanalytical strategies